DUBLIN, August 12, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Stroke: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis" report to their offering.
Due to their extended dosing durations, patients receiving treatment for the secondary prevention of ischemic stroke are the most commercially relevant patient subgroup.
This report addresses the following questions:
How will the approval of andexanet alfa as an antidote for Xarelto impact the drug's sales?
- Which patient subgroups will have the greatest impact on a drug's sales in ischemic stroke?
- What are the most important factors influencing physicians' prescribing trends?
- Which branded treatment for ischemic stroke will have the largest market share in 2024?
- What are the most commonly prescribed therapies for both the acute treatment and secondary prevention of ischemic stroke?
Key Topics Covered:
FORECAST: ISCHEMIC STROKE
- Market Overview and Trends
- Market Definition and Methodology
- Brilinta (ticagrelor)
- Plavix (clopidogrel)
- Xarelto (rivaroxaban)
- Primary Research Methodology
TREATMENT: ISCHEMIC STROKE
- Primary Research Methodology
- Disease Definition and Diagnosis
- Current Treatment Options
- Prescribing Trends
EPIDEMIOLOGY: STROKE
- Disease Background
- Sources and Methodology.
- Forecast
- Epidemiologist Insight
- Strengths and Limitations
MARKETED DRUGS: ISCHEMIC STROKE
- Product Overview
- Product profile: Activase
- Product profile: Aggrenox
- Product profile: Plavix
PIPELINE: ISCHEMIC STROKE
- Clinical Pipeline Overview
- Recently Discontinued Drugs
- Product profile (late stage): Ampyra
- Product profile (late stage): Brilinta
- Product profile (late stage): Xarelto
For more information about this report visit http://www.researchandmarkets.com/research/5rxhtt/stroke
Related Topics: Cardiovascular Drugs
Media Contact:
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article